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Abstract
Almost all cases of sporadic amyotrophic lateral sclerosis (ALS), and some cases of the familial form, are characterised by the
deposition of TDP-43, a member of a family of heteronuclear ribonucleoproteins (hnRNP). Although protein misfolding and
deposition is thought to be a causative feature of many of the most prevalent neurodegenerative diseases, a link between
TDP-43 aggregation and the dysfunction of motor neurons has yet to be established, despite many correlative
neuropathological studies. We have investigated this relationship in the present study by probing the effect of altering TDP-
43 aggregation behaviour in vivo by modulating the levels of molecular chaperones in a Drosophila model. More specifically,
we quantify the effect of either pharmacological upregulation of the heat shock response or specific genetic upregulation of
a small heat shock protein, CG14207, on the neurotoxicity of both TDP-43 and of its disease associated 25 kDa fragment
(TDP-25) in a Drosophila model. Inhibition of the aggregation of TDP-43 by either method results in a partial reduction of its
neurotoxic effects on both photoreceptor and motor neurons, whereas inhibition of the aggregation of TDP-25 results not
only in a complete suppression of its toxicity but also its clearance from the brain in both neuronal subtypes studied. The
results demonstrate, therefore, that aggregation plays a crucial role in mediating the neurotoxic effects of both full length
and truncated TDP-43, and furthermore reveal that the in vivo propensity of these two proteins to aggregate and their
susceptibility to molecular chaperone mediated clearance are quite distinct.
Citation: Gregory JM, Barros TP, Meehan S, Dobson CM, Luheshi LM (2012) The Aggregation and Neurotoxicity of TDP-43 and Its ALS-Associated 25 kDa
Fragment Are Differentially Affected by Molecular Chaperones in Drosophila. PLoS ONE 7(2): e31899. doi:10.1371/journal.pone.0031899
Editor: Harm Kampinga, University Medical Center Groningen, University of Groningen, Netherlands
Received October 24, 2011; Accepted January 14, 2012; Published February 22, 2012
Copyright:  2012 Gregory et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by the International Journal of Experimental Pathology (JMG), which is a non-profit-making institution; the James Baird Fund
(JMG); the Royal Society (SM); and the Biotechnology and Biological Sciences Research Council (LML, TPB, and CMD). The funders had no role in study design, data
collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: lml25@cam.ac.uk
Introduction
Although the ability to form intractable aggregates is an intrinsic
property of all polypeptide chains, the formation of such species
under physiological conditions is largely restricted to a subset of
proteins associated with progressive pathological conditions [1,2].
In particular, protein aggregation is a common feature of an
increasingly prevalent group of neurological disorders that include
Alzheimer’s disease (AD) and Parkinson’s disease (PD). A large
body of genetic and pathological evidence indicates that the
formation of such protein aggregates is a primary cause of
neuronal dysfunction, and ultimately of neurodegeneration, in the
case of both AD and PD. However, in almost all cases of sporadic
and certain cases of inherited forms of amyotrophic lateral sclerosis
(ALS) as well as a subtype of frontotemporal lobar degeneration
with ubiquitin-positive inclusions (FTLD-U), such a link between
the formation of protein aggregates and neurodegeneration
remains to be established. Indeed, whilst both of these disorders
are characterised by the formation of cytoplasmic and nuclear
deposits of the protein TDP-43, they are also distinguished by its
mislocalisation and a range of post-translational modifications
including hyperphosyphorylation, ubiquitination and truncation,
any one of which could result in loss of the normal function of
TDP-43 as a regulator of transcription and splicing [3].
In order to investigate the molecular origins of ALS and related
disorders, a number of cellular and animal models of TDP-43
expression have now been established. Whilst some of these
models have indicated a toxic gain of function role for TDP-43 in
protein aggregation and neurodegeneration, others have suggested
that the cause of neuronal dysfunction is the loss of normal TDP-
43 function, or indeed that the retention of the RNA binding
activity of TDP-43 resulting in aberrant binding is a cause of its
toxicity [4–6]. A further complicating factor in the interpretation
of many of these studies is the need to account for the
neurotoxicity not only of the full length TDP-43 protein, which
could retain functional activity, but also of the non-functional N-
terminally truncated 25 kDa fragment of TDP-43 that is found
specifically in the brains of patients affected with ALS and FTLD-
U [3].
In the present study we set out to investigate specifically the role
of aggregation of full length TDP-43 and of an N-terminally
truncated and disease-associated fragment, TDP-25, in causing
neurodegeneration by upregulation of molecular chaperones, the
inherent machinery of all biological systems that combats
misfolding and aggregation; it is well established that molecular
chaperones are able to inhibit the aggregation of proteins
associated with neurodegenerative diseases [7,8]. Furthermore,
neuropathological studies, demonstrating the colocalisation of
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diseases, and animal model studies, showing that they can inhibit
protein aggregation and neurodegeneration in vivo, clearly indicate
that these molecules play an important role in the regulation of
pathological protein aggregation [9–11].
Many neurodegenerative disorders, including AD, PD and
Huntington’s disease (HD) have been modeled in Drosophila
melanogaster, and these model systems have been formed to capture
many of the key molecular features of these diseases [12–15].
Here, we describe the construction of a Drosophila model of TDP-
43 proteinopathy and demonstrate that both pharmacological and
genetic upregulation of chaperones enable a dissection of the
distinct roles played by aggregation in neurodegeneration induced
both by TDP-43 and its N-terminally truncated fragment TDP-25.
Results
A Drosophila model of TDP-43 proteinopathy
In order to evaluate the aggregation and neurotoxicity of both
full length TDP-43 and its disease associated, N-terminally
truncated 25 kDa fragment (TDP-25), two lines of transgenic
Drosophila were generated, each expressing one of these proteins. In
the first line, the human TARDBP gene was introduced into the
Drosophila genome using a modified UAS-GAL4 vector [16], and in
the second line a gene encoding the TDP-25 fragment that had
been truncated at the putative caspase-3 cleavage site between
residues 216–219 was introduced in to the Drosophila genome in the
same way (Figure 1A) [17]. Both constructs were incorporated into
identical genomic loci to ensure that each is transcribed in the flies
at the same level and to allow quantitative comparisons to be made
between their resulting phenotypes [18]. This method has been
demonstrated previously to be an effective way of ensuring
equalisation of transcription rates for different transgenes in
Drosophila [19].
Expression of aggregation prone proteins associated with
neurodegenerative diseases in the photoreceptors of Drosophila
typically cause a characteristic ‘rough eye’ phenotype in which the
normal linear array of ommatidia and sensory bristles become
disordered, and in addition the eye loses its natural pigmentation
to varying degrees that depend on the toxicity of the proteins
Figure 1. Neurotoxicity of TDP-43 expression in Drosophila melanogaster. A) Scheme of constructs used for expression. Both constructs have
an HA-tagged N-terminus. The nuclear localisation sequence (NLS) [39] is indicated by two black rectangles between residues 82 and 98, the RNA-
recognition motifs (RRM) [39] or RNA-binding domains (RRM 1, between residues 106 and 175, and RRM2, between 191 and 262) are indicated by two
gray rectangles, and the nuclear export sequence (NES) is represented by the black rectangle between residues 239 and 250 within RRM 2.
Arrowheads indicate caspase cleavage sites at residues 89 and 219 [40]. B) Optical and scanning electron microscope images demonstrating the
effects of the TDP-43 and TDP-25 constructs when expression is driven in the photoreceptor neurons with gmr-GAL4. Colour pictures represent
optical micrographs, taken at 7.56magnification, of fly eyes and flies of the same genotype imaged using a scanning electron microscope at 2006
magnification are shown in the adjacent picture. Scale bars represent 20 mm. C) Low and high magnification confocal microscopy images of imaginal
eye discs of third instar larvae expressing TDP-43 or TDP-25 in the photoreceptors under the control of gmr-GAL4. TDP-43 and TDP-25 distribution is
shown by anti-HA (red) staining, anti-ubiquitin (green) reveals ubiquitinated species, and TOTO-3 (blue) reveals nuclei. White arrowheads indicate
aggregates, white arrows indicate the location of the morphogenetic furrow, and white boxes represent the area shown at higher magnification. Low
magnification scale bars=100 mm and high magnification scale bars=10 mm.
doi:10.1371/journal.pone.0031899.g001
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and scanning electron microscopy. Expression of TDP-43 and
TDP-25 in this way using the gmr-GAL4 driver was found to result
in a rough eye phenotype in both cases, although its severity was
observed to vary dramatically between the two genotypes. Thus,
flies expressing TDP-43 have a strong rough eye phenotype,
characterised by an almost complete absence of structured
ommatidia when examined by either optical or scanning electron
microscopy, whereas TDP-25 flies show only a weak phenotype
that is only clearly evident on high magnification analysis using
scanning electron microscopy (Figure 1B).
The rough eye phenotypes elicited by expression of the full
length and the truncated TDP-43 constructs are both associated
with microscopic signs of protein aggregation. Immunohistochem-
ical analysis of the developing eye disc reveals the presence of
TDP-43 both in the cytoplasm and in the nuclei of cells anterior to
the morphogenetic furrow where gmr driven expression occurs
(Figure 1C). Strikingly, the aggregates of both forms of TDP co-
stained for ubiquitin, which is a feature of the deposits of TDP-43
found in ALS and FTLD-U brains (Figure 1C). Small puncta
typical of protein aggregates are also visible. In marked contrast,
similar analysis of TDP-25 flies indicates that there are
predominantly individual large aggregate structures in the cell,
found only in the most anterior region of the eye disc. The anterior
region of the eye disc is where gmr driven protein expression has
been activated for significantly longer than in more posterior cells
closer to the morphogenetic furrow [21].
The strong correlation between the length of time for which
TDP-25 has been expressed across the anterior-posterior axis of
the eye disc and the extent to which it accumulates in cells along
this axis, suggests that TDP-25 may be more susceptible to
proteostatic regulation than TDP-43, which is distributed more
uniformly along this axis. This conclusion is also consistent with
the observation that the total number of aggregates and the
intensity of staining of TDP-25 detectable in the eye disc by
confocal microscopy is dramatically lower than that of TDP-43
(Figure 1C). Whilst these data are suggestive that aggregation
could play a role in TDP-43 and TDP-25 induced neurodegen-
eration, we sought to test this association more directly by
abrogating protein aggregation through chaperone upregulation
and examining the effect on the toxic phenotypes observed for
both proteins.
17-AAG treatment reduces aggregation of both TDP-43
and TDP-25
17-AAG, an analogue of the Hsp90 inhibitor geldanamycin, has
been shown to up-regulate the heat shock response via activation
of Hsf1, which itself regulates the transcription of a range of
chaperones in Drosophila, and to abrogate the aggregation and
toxicity of polyglutamine-containing proteins and a-synuclein in
Drosophila and in cell cultures [22,23]. We treated flies expressing
TDP-43 and TDP-25 in their photoreceptors with 1.5 mM 17-
AAG and observed the effects on the eye phenotypes described
above. This treatment resulted in a partial rescue of the rough eye
phenotype associated with TDP-43 expression (Figure 2A) as the
eyes were of a more normal shape and size, were more intensely
pigmented and had better defined ommatidia (Figure 2B),
compared to those that were not treated. Nevertheless the eyes
remained significantly dysmorphic when compared to non-
transgenic controls. Immunohistochemical detection revealed that
treatment with 17-AAG resulted in a significant reduction in the
appearance of punctate aggregates of TDP-43, a redistribution of
the protein into a more diffuse staining pattern throughout the
cytoplasm and the nuclei of cells, and also the appearance of
staining in more posterior cells within the eye disc (Figure 2C).
This apparent inhibition of aggregation is supported by the results
of SDS PAGE and western blot analysis in which the insoluble
fractions of proteins extracted from fly heads were almost
completely depleted of TDP-43 when flies had been treated with
17-AAG (Figure 2D).
The response of flies expressing TDP-25 to treatment with 17-
AAG was observed to be quite distinct from that of TDP-43. In
this case, the mild rough eye phenotype elicited by TDP-25
expression was completely rescued and, instead of causing a
redistribution from punctate into more diffuse staining across a
wider number of more posterior cells within the eye disc, as was
observed for TDP-43, 17-AAG treatment results in the complete
clearance of TDP-25 from the photoreceptor cells (Figure 2C). By
contrast to western blot analysis of TDP-43, similar experiments
performed on insoluble protein fractions extracted from flies
expressing TDP-25, revealed that no protein could be detected by
this method. This finding is also consistent with previous
observations of a similar N-terminally truncated TDP-43 fragment
in Drosophila in which expression could only be confirmed by RT-
PCR [19].
Chaperone upregulation reveals different relationships
between aggregation and toxicity for TDP-43 and TDP-25
17-AAG is known to have pleiotropic effects on the regulation of
multiple cellular processes, including autophagy and apoptosis, as
well as inducing chaperone expression [22,24,25]. Thus, in order
to explore whether aggregation could be modulated more
specifically, we proceeded to examine the effects of genetic
upregulation of the heat shock protein CG14207 that is intrinsic to
Drosophila and has sequence homology with human aB-crystallin
and human HspB8. This chaperone has been found previously in
a genetic screen to reduce the neurotoxicity of the poly-glutamine
containing protein ataxin 3 associated with spinocerebellar ataxia
type 3 (SCA3), a disease that exhibits a similar cytoplasmic
aggregation phenotype to the TDP-43 proteinopathies [26,27]. In
this previous study the authors established that the transgenic line
EP 1348, used for the over-expression of CG14207, was indeed
specifically activating the correct gene and not other transcription
units close to the P-element insertion site. Due to the well-
characterised nature of this chaperone line in Drosophila,w e
decided that CG14207 was an excellent candidate to establish
whether chaperones can affect the aggregation and the subsequent
toxicity of TDP-43 and TDP-25.
Flies overexpressing CG14207 were crossed with those ex-
pressing TDP-43 and TDP-25, and the effects on their neurotoxic
phenotypes were monitored. A very similar pattern of results was
obtained to those observed with 17-AAG treatment, as CG14207
expression is only partially able to rescue the neurotoxic effect of
TDP-43 on developing photoreceptors (Figure 3A), and redistri-
bution of TDP-43 to more diffuse cytoplasmic and nuclear
staining patterns is observed. The level of TDP-43 detected in the
insoluble fraction of protein extracts from fly head homogenates,
analysed by western blot and SDS PAGE, was also reduced almost
two-fold. By contrast, the level of soluble TDP-43, either observed
in immunostained eye discs or by western blot analysis following
SDS PAGE under reducing conditions, is actually increased upon
co-expression with CG14207, indicating that the inhibition of its
aggregation is not associated with an increase in its clearance
(Figure 3B). There is, however, a significant reduction in the
amount of high molecular mass, oligomeric species in the soluble
fraction under non-reducing conditions when CG14207 is present
(Figure 3C), indicating that TDP-43 is either stabilised in its
monomeric form or readily incorporated into insoluble aggregates.
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where the TDP-25 neurotoxic rough eye phenotype is mild in
comparison to that elicited by TDP-43 expression, complete
rescue upon CG14207 co-expression was observed. It was
important to determine whether the difference in the extent of
the rescue by CG14207 of TDP-43 and TDP-25 toxicity was
indeed due to the two proteins having different intrinsic
susceptibilities to CG14207 activity or is attributable to the
apparently lower steady state concentration of TDP-25 present
compared to TDP-43. To address this question a stronger gmr-
GAL4 driver was used, which was able to drive expression of TDP-
25 to a much higher level than that achieved by the driver used in
Figure 3a-c. Even when TDP-25 expression was increased in this
way, resulting in larval lethality, it was still possible to observe a
complete rescue of TDP-25 toxicity, as measured by a restoration
in adult viability and eye morphology comparable to driver only
controls, when CG14207 was co-expressed (Figure 3D). Further-
more we show that the rescue by CG 14207 does not simply reflect
reduced expression of the transgene resulting from over-expression
of another protein, as when we co-express TDP-43 with GFP,
which has no chaperone activity, we see no rescue of the toxic
phenotype (Figure S1). As observed for 17-AAG treatment, this
rescue was accompanied by a complete clearance of the TDP-25
protein from the photoreceptor cells, as seen by immunohisto-
chemistry and western blot analysis following SDS PAGE under
non-reducing conditions. In addition, western blot analysis, under
non-reducing conditions, shows that TDP-25 can be observed in
the soluble fraction as bands of high molecular mass oligomers, but
not as a monomer, and these species are completely cleared upon
co-expression with CG14207 (Figure 3C). This striking difference
in behaviour between TDP-43 and TDP-25 suggests that whilst
TDP-25 can readily be degraded by the cell if it is prevented from
aggregating by chaperones, TDP-43 remains substantially more
resistant to clearance.
Chaperone upregulation has differential effects on
neuronal dysfunction when TDP-43 and TDP-25 are
expressed in adult motor neurons
As ALS is a disease affecting the motor neurons, we examined
the effects of the expression of TDP-43 and TDP-25 in motor
neurons of adult flies (under the control of a heat-shock activated
D42-GAL4 driver). The median lifespans of the flies in which TDP-
43 or TDP-25 expression was driven in these motor neurons were
Figure 2. 17-AAG treatment suppresses aggregation of TDP-43 and its disease associated fragment. A) Optical micrographs of flies
expressing TDP-43 or TDP-25 treated with 17-AAG compared to untreated controls of the same genotype. B) Scanning electron microscope images of
fly eyes taken at 2006magnification, scale bars represent 20 mm. C) Fluorescent confocal microscope images show the reduction in aggregation of
TDP-43 and TDP-25 in the photoreceptors upon 17-AAG treatment compared to untreated flies of the same genotype. TDP isoforms are detected by
anti HA staining (red) and nuclei by TOTO-3 staining (blue). D) Western blot revealing insoluble (9 M urea soluble) fractions of TDP-43 and TDP-25
from fly head homogenates in the presence or absence of 17-AAG, using an anti-HA antibody. b-actin was used as a loading control.
doi:10.1371/journal.pone.0031899.g002
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control flies (Figure 4A; p,0.05). Co-expression of CG14207 with
TDP-43, however, revealed a significant rescue in the toxic
phenotype as flies show only a 2866% reduction in median
lifespan compared to control flies (p,0.05). By contrast flies co-
expressing CG14207 with TDP-25 showed no significant differ-
ence in lifespan compared to wild type flies, indicating complete
rescue. As the selective degeneration of upper and lower motor
neurons is pathognomic for ALS, we also sought to investigate
motor neuron function using a locomotor assay. From 8 days of
Figure 3. Genetic upregulation of an endogenous Drosophila chaperone reduces toxicity of TDP-43 and its disease associated
fragment. A) Light and scanning electron microscope images demonstrating the effects of the TDP-43 and TDP-25 constructs when expression is
driven by gmr-GAL4, in the presence and absence of co-expression of the chaperone CG14207. Light micrographs taken at 7.56magnification, of fly
eyes and inset are flies of the same genotype imaged using a scanning electron microscope at 2006 magnification. Adjacent are low and high
magnification confocal microscopy images of imaginal eye discs of third instar larvae. TDP-43 and TDP-25 distribution is shown by anti-HA (red)
staining. TOTO-3 (blue) detects nuclei. White arrowheads indicate aggregates. White arrows indicate the location of the morphogenetic furrows and
white boxes represent the areas shown at higher magnification. Low magnification scale bars=100 mm and high magnification scale bars=10 mm. B)
Western blot detecting soluble (RIPA soluble) and insoluble (9 M urea soluble) fractions of TDP-43 and TDP-25 from fly brain homogenates in the
presence or absence of the co-expression of CG14207, under reducing conditions. b-actin was used as a loading control. C) Western blot detecting
soluble (RIPA soluble) fractions under non-reducing conditions, using an anti-HA antibody. b-actin was used as a loading control. D) Light microscope
images demonstrating the effects of the TDP-25 construct when expression is driven by a different gmr-GAL4 driver, which generates expression to a
greater extent than that used previously, in the presence and absence of the co-expression of CG14207. Light micrographs of Drosophila eyes taken
at 76magnification.
doi:10.1371/journal.pone.0031899.g003
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rapid decline in locomotor ability that is not observed in age
matched non-transgenic flies (Figure 4B). Flies expressing TDP-25
were not, however, found to experience a significant decline
relative to non-transgenic controls until 16 days of age, consistent
with the relative toxicities observed when these two proteins are
expressed in the eye. Co-expression of CG14207 with TDP-43
substantially reduces locomotor deficits compared to expression of
TDP-43 alone, but the effect is only to reduce the rate of decline,
with flies expressing CG14207 and TDP-43 still becoming
immobile earlier than non-transgenic flies. Co-expression of
CG14207 with TDP-25 not only reduced the locomotor deficit
induced by TDP-25, but restored locomotor function to the same
level as that measured for wild type flies at all ages measured.
Progressive diminution in the longevity and locomotor function of
flies expressing TDP-43 with age is therefore associated with the
accumulation of these proteins in the cytoplasm and in the nucleus.
Immunohistochemical analysis of adult brains dissected from 10-day-
old flies was carried out (Figure 5A), and co-expression of CG14207
was found to lead to a shift towards a more diffuse distribution of
TDP-43 immunostaining within neurons. In order to examine
whether or not this change in immunostaining reflects a change in the
presence of aggregated forms of TDP-43, extracts from the brains of
10-day-old flies were analysed by SDS PAGE and western blotting
(Figure 5B). In the absence of co-expression of CG14207, TDP-43
can be detected in both the detergent soluble and insoluble fractions,
with the majority of protein being present in the insoluble fraction,
indicating that it forms aggregates within the motor neurons in which
it is expressed. Co-expression of CG14207 with TDP-43, however,
results in a significant redistribution of the protein as the majority in
this case was detected in the soluble fraction of fly head protein
extracts.Bycontrastsimilarimmunohistochemicalanalysisof10-day-
old flies expressing TDP-25 reveals that the ability of CG14207 to
suppress completely the modest effect of TDP-25 on locomotor
behaviour in the adult is associated with a complete clearance of
TDP-25 from the neurons in which it is expressed, a finding
consistent with our observations of TDP-25 toxicity in the eye.
Discussion
Many cellular, invertebrate and vertebrate models of TDP-43
proteinopathy, based on the expression of full length, mutated,
Figure 4. Chaperone upregulation has differential effects on neuronal dysfunction when TDP-43 is expressed in the adult motor
neurons. A) Plot showing the Kaplan Meier survival data of TDP-43 and TDP-25 when expressed in adult motor neurons using a temperature
sensitive Gal80 D42-GAL4 driver compared to non-transgenic flies (WT). Lifespans were analysed by Kaplan-Meier statistics, n=100 grouped into 10
tubes of 10 flies per genotype, differences between genotypes were analysed by Mann-Whitney U tests. B) Graph representing differences in motor
function, analysed by climbing assay, when expressing TDP-43 and TDP-25 with and without CG14207 in adult motor neurons using the Gal80-D42-
GAL4 driver.
doi:10.1371/journal.pone.0031899.g004
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first reports emerged of the neuropathological and genetic role of
this protein in FTLD-U, ALS and many other neurodegenerative
diseases [5,28–30]. Reports describing these models have variously
suggested that motor or cortical neuron degeneration is correlated
with the loss of endogenous TDP-43 from the nucleus [31], the
presence of cytoplasmic or nuclear aggregates of full length or
fragments of TDP-43 [4,19,32,33], retention of the functional
RNA binding domains of TDP-43 [4,19] or the aggregation of the
C-terminal fragment of TDP-43 [34]. However, variations in the
construction of these models, and their reliance on making post
hoc correlations between their histopathological characteristics
and the loss of motor neurons, makes it very challenging to assess
the significance of these different conclusions.
In the present study we set out to address directly the fund-
amental question of the role played by the aggregation of TDP-43
in its neurotoxicity by investigating the effects of increasing the
intrinsic ability of cells to prevent protein aggregation by
modulating molecular chaperones. This approach has allowed us
to manipulate aggregation in a controlled manner and then to
make quantitative comparisons of the neurotoxicity of TDP-43
with or without suppression of its aggregation. In order to achieve
this objective we established a Drosophila model in which expression
of TDP-43 and an ALS-associated 25 kDa fragment, TDP-25, can
be driven in selected tissues so as to generate similar patterns of
aggregation and neurodegeneration to those observed in FTLD
and ALS patients.
The results suggest that the C-terminal fragment, TDP-25,
which in vitro studies indicate is more aggregation prone than full
length TDP-43 is, nevertheless, significantly less toxic than TDP-
43 [35]. In addition, we find that steady state levels of TDP-25 are
significantly lower than those observed for TDP-43 despite their
transcription from identical genomic loci, suggesting that TDP-25
is cleared more efficiently than TDP-43, a finding consistent with
observations from other studies in both C. elegans and D. melanogaster
[19,36]. This result provides an explanation for its reduced
pathogenicity, which can be attributed to the fact that the
truncation is likely to destabilise the protein, resulting in a
disordered structure that is more susceptible to degradation. TDP-
25 causes only a relatively late onset reduction in motor abilities
when expressed in Drosophila motor neurons, and accelerates the
normal decline in locomotor ability by only 10–15% in our model.
Furthermore it causes only a mild rough eye phenotype compared
to TDP-43. Moreover these impairments can be completely
rescued by genetic upregulation of the chaperone CG14207,
resulting in the complete clearance of TDP-25 aggregates even
Figure 5. Chaperone upregulation reduces aggregation analysed by immunohistochemistry and SDS PAGE. A) Confocal microscope
images showing the reduction in aggregation of all TDP isoforms in the adult motor neuron cell bodies in the 10-day-old brain upon co-expression
with CG14207 compared to flies not expressing CG14207, 10 days after induction of expression. TDP isoforms are detected by anti-HA staining (red)
and nuclei by TOTO-3 staining (blue). Scale bars=10 mm. B) Western blot detection of RIPA soluble and urea soluble fractions of TDP-43 from fly head
homogenates in the presence or absence of the co-expression of CG14207 under reducing conditions, using an anti-HA antibody. b-actin was used as
a loading control.
doi:10.1371/journal.pone.0031899.g005
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stronger gmr driver. This result indicates that the misfolding and
aggregation of this fragment accounts completely for its neurotoxic
effects. These results raise the issue of the extent to which the
generation and aggregation of this fragment, which is specifically
detected in patients suffering from FTLD-U or ALS, could be the
cause of the underlying neurodegeneration observed in these
diseases.
We also find that chaperone upregulation, and subsequent
reductions in the microscopic and biochemical detection of
aggregates of TDP-43, is associated with a reduction in its
pathogenic effects demonstrated by photoreceptor degeneration or
motor neuron dysfunction. In the case of flies expressing TDP-43,
unlike those expressing TDP-25, this reduction in toxicity is
incomplete, a finding consistent with the continued presence of
aggregated TDP-43 that we have demonstrated biochemically by
the detection of urea insoluble protein, albeit at much lower levels,
in the brains of Drosophila when it is co-expressed with CG14207.
This result is likely to reflect the inability of CG14207 expression,
at the levels achieved by these experiments, to prevent or reverse
completely the formation of toxic TDP-43 aggregates. Indeed it
has been shown previously that other chaperones containing
crystallin domains (homologous to those present in CG14207),
such as a-crystallin and aB-crystallin may prevent the formation of
insoluble, amyloid fibrils of other proteins but, depending on their
stoichiometric ratios with respect to their client proteins, may also
stabilise or even enhance the formation of relatively soluble but
potentially neurotoxic non-fibrillar aggregates [37].
In conclusion we have exploited the upregulation of chaperones
to probe the in vivo aggregation behaviour of TDP-43 and TDP-
25, and its relationship with neurotoxicity. Our results demon-
strate that whilst both TDP-43 and TDP-25 form aggregates in
vivo, the abundance of these aggregates, the ease with which they
can be prevented from forming by the small heat shock protein
CG14207 and their neurotoxic effects are very substantially
different. The important role of aggregation in the TDP-43
proteinopathies is therefore consistent with our understanding of
other protein misfolding diseases such as AD, PD and HD.
Methods
Generation of transgenic Drosophila and fly stocks
HA-tagged TDP-43 constructs were codon optimised for
expression in D. melanogaster and synthesised by Genscript (Piscat-
away, NJ, USA). Each construct was cloned into the multiple
cloning site of pUAST-AttB and then subcloned into a modified
pCasper vector (pCa4B, a kind gift of M. Markstein and N.
Perrimon, Harvard University, USA). Differences in the expres-
sion of the constructs that could arise from their integration at
different genomic loci were therefore eliminated as the pCa4B
vector contains sites for exploiting the PhiC31 system for site-
specific integration of transgenes. All injected constructs were
incorporated at the same genomic locus (51D) on Chr. II (Bestgene
Inc, USA) [18]. All other fly stocks used were obtained from
Bloomington Stock Centre, Indiana, USA.
Optical and scanning electron microscopy
TDP-43 and TDP-25 flies were crossed with gmr-GAL4 flies
(Bloomington Stock ID: 1104 & 8121). All flies were kept in a
temperature and humidity controlled incubator maintained at
25uC, 70% humidity. Optical microscope pictures were taken of 1-
day-old TDP/gmr-GAL4 offspring at a magnification of 7.56. SEM
images were collected as described previously [12].
Immunohistochemistry
Third-instar larval imaginal eye discs and adult brains were
dissected, fixed in 4% PFA and blocked in 5% BSA in 0.05%
PBS-Triton. This procedure was followed by incubation over-
night with rat anti-HA-biotin high affinity antibody (Clone 3F10,
Roche) and mouse anti-ubiquitin antibody (P4D1, Cell Signal-
ling). Discs or brains were then incubated overnight in Strep-
tavidin Alexa Fluor 594 conjugate (Invitrogen) and anti-mouse
FITC, and counterstained with TOTO-3 (Invitrogen) to detect
nucleic acids.
Western blot analysis
Five flies per genotype were decapitated, homogenised in RIPA
buffer and centrifuged to pellet the insoluble forms of proteins.
The pellets were then resuspended in 9 M urea and centrifuged
again to collect urea soluble protein. Each of the protein samples
was separated on 4–12% Bis-Tris gel (Invitrogen) under reducing
or non-reducing conditions and transferred to PVDF membranes
(Millipore). Blots were blocked with 5% non-fat milk and then
incubated with primary antibodies: anti-HA-biotin, high affinity
(3F10) antibody (Roche) followed by incubation with anti-rat
secondary antibody conjugated to HRP. Bands were detected
using a SuperSignalH West Femto Maximum Sensitivity Substrate
kit (Thermo Scientific). Loading controls using a mouse anti-b-
actin antibody (Abcam) and anti-mouse HRP (Dako) were
performed on all western blots.
Geldanamycin treatment
The geldanamycin analogue 17-allylamino geldanamycin (17-
AAG; Sigma) was resuspended in ethanol and diluted in distilled
water to a concentration of 1.5 mM. 300 mL aliquots of drug were
added to the surface of pre-made fly food and allowed to dry for 2
days. TDP-43 and TDP-25 flies were crossed with gmr-GAL4 flies
and maintained on either standard cornmeal-agar food treated
either with distilled water or 1.5 mM 17-AAG to allow the larvae
to ingest the drug. Microscopy, immunohistochemistry and
western blot analyses were performed on drug treated and control
offspring as described above.
Longevity assay
Crosses were set up at 25uC. Non-virgin females were kept 10
per vial and moved to 29uC within 24 hours of eclosion and were
transferred to fresh food and counted every 2–3 days. The
experiments were performed in a temperature-controlled incuba-
tor at 29uC. Temperature sensitive Gal80 D42-GAL4 is activated
by heat shock and so simply moving flies from 25uCt o2 9 uC
induces expression in motor neurons. Median survivals for each
vial were calculated using Kaplan-Meier survival statistics (n=100
per experiment) and differences between genotypes were analysed
using a Mann-Whitney U test (n=10 tubes of 10 flies each).
Climbing assay
Motor function was assessed by a climbing assay. Flies
expressing TDP-43 and TDP-25 in motor neurons from the day
of hatching, with and without CG14207, were generated in
separate experiments as described above. 10 flies were placed into
a single tube and analysed every second day after the initial heat
shock; this procedure was repeated three times on the same tube of
flies for each day. A climbing index score was calculated as
described previously [38]. The average climbing index of the three
replicates was calculated for each time point and plotted on a
graph.
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Figure S1 Light microscope images demonstrating the
effects of TDP-43 when expression is driven by gmr-
GAL4, in the presence and absence of a non-toxic control
protein (UAS-GFP).
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